LDK378

Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.

Target : ALK

CAS Number : 1032900-25-6

Formula Weight : 558.14

Molecular Formula : C28H36ClN5O3S

Purity : >98%(HPLC)

Storage : (-20?)

Shipping Conditions : With Ice Pack

Stability : ? 2 years

Research use only, not for human use.